Summary
Possible neurotoxic actions of intracerebral injections of ibotenic acid, a conformationally restricted analogue of glutamic acid, have been evaluated in rat brain and compared with those of kainic acid.
Light microscopical analysis revealed that ibotenic acid produced a marked disappearance of nerve cells in all areas studied, namely striatum, the hippocampal formation, substantia nigra and piriform cortex. Lesions in areas distant to the injection site were not seen. Axons of passage and nerve terminals of extrinsic origin did not seem to be damaged, since, e.g., no apparent degeneration of the dopaminergic terminals in the neostriatum was observed except for a small area surrounding the cannula. In the neostriatum, enkephalin immunoreactive neuronal cell bodies as well as nerve terminals disappeared after injection of ibotenic acid into this nucleus. After injection into the substantia nigra tyrosine hydroxylase immunoreactive cell bodies in the zona compacta disappeared, whereas no certain effect could be seen on the enkephalin immunoreactive nerve fibers.
In vitro experiments, conducted with striatal synaptosomal and membrane preparations, showed that ibotenic acid differed from kainic acid by being devoid of a significant inhibitory effect on high affinity glutamate uptake and by having a low affinity for 3H-kainic acid binding sites. Furthermore, ibotenic acid did not interfere with the binding of a number of radioligands for other transmitter receptors.
As compared to kainic acid, ibotenic acid has the advantage of being less toxic to the animals and of producing more discrete lesions, possibly due to faster metabolism and/or other fundamental biochemical differences. Because of these special features, ibotenic acid seems to represent a valuable new tool in the morphological and functional analysis of central neuronal systems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allan, R.D.: The synthesis of a decarboxylated derivative of the neurotoxin kainic acid. Tetrahedron Lett. 25, 2199–2200 (1978)
Andén, N.-E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.-Å., Larsson, K.: Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3, 523–530 (1964)
Biziere, K., Coyle, J.T.: Effects of kainic acid on ion distribution and ATP levels of striatal slices incubated in vitro. J. Neurochem. 31, 513–520 (1978a)
Biziere, K., Coyle, J.T.: Influence of corticostriatal afferents on striatal kainic acid neurotoxicity. Neurosci. Lett. 8, 303–310 (1978b)
Bylund, D.B., Snyder, S.H.: Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol. Pharmacol. 12, 568–580 (1976)
Childers, S.R., Schwarcz, R., Coyle, J.T., Snyder, S.H.: Radioimmunoassay of enkephalins: levels of methionine- und leucine-enkephalin in morphine-dependent and kainic acid-lesioned rat brains. In: Advances in biochemical pharmacology (eds. E. Costa, M. Trabucchi), pp. 161–173. New York: Raven Press 1978
Coons, A.H.: Fluorescent antibody methods. In: General cytochemical methods (ed. J.F. Danielli), pp. 399–442. New York: Academic Press 1958
Coyle, J.T., Schwarcz, R.: Lesion of striatal neurons with kainic acid provide a model for Huntington's Chorea. Nature (Lond.) 263, 244–246 (1976)
Coyle, J.T., Molliver, M.E., Kuhar, M.J.: In situ injection of kainic acid: a new method for selecively lesioning neuronal cell bodies while sparing axons of passage. J. Comp. Neurol. 180, 301–324 (1978)
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62, Suppl. 232, 1–55 (1964)
Enna, S.J., Snyder, S.H.: Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions. Brain Res. 100, 81–97 (1975)
Eugster, C.H.: Wirkstoffe aus dem Fliegenpilz. Naturwissenschaften 55, 305–313 (1968)
Fields, J.Z., Reisine, T.D., Yamamura, H.I.: Biochemical demonstration of dopaminergic receptors in rat and human brain using (3H) spiroperidol. Brain Res. 136, 578–584 (1977)
Foster, A.C., Roberts, P.J.: High affinity L-/3H/ glutamate binding to postsynaptic receptor sites on rat cerebellar membranes. J. Neurochem. 31, 1467–1477 (1978)
Greenberg, D.A., U'Prichard, D.C., Snyder, S.H.: Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. Life Sci. 19, 69–76 (1976)
Hökfelt, T., Fuxe, K., Goldstein, M., Park, D.: Immunohistochemical studies of three catecholamine synthesizing enzymes: aspects on methodology. Histochemie 33, 231–254 (1973)
Hökfelt, T., Johansson, O., Fuxe, K., Goldstein, M., Park, D.: Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. II. Tyrosine hydroxylase in the telencephalon. Med. Biol. 55, 21–40 (1977)
Hong, J.S., Yang, H.Y.T., Costa, E.: On the localization of methionine enkephalin neurons in rat striatum. Neuropharmacology 16, 451–453 (1977)
Johnston, G.A.R., Curtis, D.R., de Groat, W.C., Duggan, A.W.: Central actions of ibotenic acid and muscimol. Biochem. Pharmacol. 17, 2488–2489 (1968)
Johnston, G.A.R., Curtis, D.R., Davies J., McCulloch, R.M.: Spinal interneuron excitation by conformationally restricted analogues of L-glutamic acid. Nature 248, 804–805 (1974)
Keller, R., Oke, A., Mefford, I., Adams, R.N.: Liquid chromatographic analysis of catecholamines — routine assay for regional brain mapping. Life Sci. 19, 995–1004 (1976)
Köhler, C., Schwarcz, R., Fuxe, K.: Perforant path transections protect hippocampal granule cells from kainate lesion. Neurosci. Lett. 10, 241–246 (1978)
McGeer, E.G., McGeer, P.L.: Duplication of biochemical changes of Huntington's Chorea by intrastriatal injection of glutamic and kainic acids. Nature 263, 517–519 (1976)
McGeer, E.G., McGeer, P.L., Singh, K.: Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract. Brain Res. 139, 381–383 (1978)
Olney, J.W., Rhee, V., Ho, O.L.: Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res. 77, 507–512 (1974)
Pease, D.C.: Buffered formaldehyde as a killing agent and primary fixative for electron microscopy. Anat. Rec. 142, 342 (1962)
Pettibone, D.J., Kaufman, N., Scally, M.C., Meyer, E. Jr., Ulus, I., Lytle, L.D.: Striatal nondopaminergic neurons: possible involvement in feeding and drinking behaviour. Science 200, 1175–1177 (1978)
Pollard, H., Llorens, C., Schwartz, J.C., Gros, C., Oray, F.: Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Res. 151, 392–398 (1978)
Ponzio, F., Jonsson, G.: A rapid and simple method for the determination of picogram levels of serotonin in brain tissue using liquid chromatography with electrochemical detection. J. Neurochem. 32, 129–132 (1979)
Schultzberg, M., Lundberg, J.M., Hökfelt, T., Terenius, L., Brandt, J., Elde, R.P., Goldstein, M.: Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience 3, 1169–1186 (1978)
Schwarcz, R., Coyle, J.T.: Striatal lesions with kainic acid: neurochemical characteristics. Brain Res. 127, 235–249 (1977a)
Schwarcz, R., Coyle, J.T.: Neurochemical sequelae of kainate injection in corpus striatum and substantia nigra of the rat. Life Sci. 20, 431–436 (1977b)
Schwarcz, R., Coyle, J.T.: Kainic acid: neurotoxic effects after intraocular injection. Invest. Ophtalmol. Visual Sci. 16, 141–148 (1977c)
Schwarcz, R., Fuxe, K., Hökfelt, T., Eugster, C.H.: Selective neuronal degeneration following intracerebral injection of ibotenic acid. Morphological and biochemical comparisons with kainic acid. In: C.I.N.P., 11th Congress, Abstr. p. 333 (1978)
Schwarcz, R., Fuxe, K., Agnati, L.F., Hökfelt, T., Coyle, J.T.: Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors. Brain Res. (in press) (1979a)
Schwarcz, R., Köhler, C., Fuxe, K., Hökfelt, T., Goldstein, M.: On the mechanism of selective neuronal degeneration in the rat brain: studies with ibotenic acid. In: Advances in neurology (eds. T.N. Chase, N. Wexler, A. Barbeau) Huntington's Chorea: 1972–1978, pp. 655–668. New York: Raven Press 1979b (in press)
Simon, J.R., Contrera, J.F., Kuhar, M.J.: Binding of 3H-kainic acid, an analogue of L-glutamate, to brain membranes. J. Neurochem. 26, 141–147 (1976)
Storm-Mathisen, J.: Glutamic acid and excitatory nerve endings: reduction of glutamic acid uptake after axotomy. Brain Res. 120, 379–386 (1977)
Wuerthele, S.M., Lovell, K.L., Jones, M.Z., Moore, K.E.: A histological study of kainic acid-induced lesions in the rat brain. Brain Res. 149, 489–497 (1978)
Yamamura, H.I., Snyder, S.H.: Muscarinic cholinergic binding in rat brain. Proc. Nat. Acad. Sci. USA 71, 1725–1729 (1974)
Yokoi, I., Takeuchi, H., Sakai, A., Mori, A.: Effects of ibotenic acid, quisqualic acid, and their relatives on the excitability of an identifiable giant neurone of an African giant snail. Experientia 33, 363–366 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwarcz, R., Hökfelt, T., Fuxe, K. et al. Ibotenic acid-induced neuronal degeneration: A morphological and neurochemical study. Exp Brain Res 37, 199–216 (1979). https://doi.org/10.1007/BF00237708
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00237708